Definium Therapeutics, Inc. (NASDAQ:DFTX) Q4 2025 Earnings Call Transcript February 26, 2026
Definium Therapeutics, Inc. reports earnings inline with expectations. Reported EPS is $-0.45 EPS, expectations were $-0.45.
Operator: Good afternoon, and welcome to the Definium Therapeutics Full Year 2025 Financial Results and Business Update Webcast. [Operator Instructions] The webcast is live on the Investor and Media section of the Definium website at definiumtx.com, and a replay will be...
